Shan Jiang is an accomplished professional with extensive experience in health economics and outcomes research, currently serving as Director of the Center for Observational & Real World Evidence at Merck since February 2021 and Director of Global Health Economics & Outcomes Research at Bayer Pharmaceuticals since April 2019. Previous roles include Senior Manager of US Health Economics & Outcomes Research in Oncology at Bristol-Myers Squibb and Scientist at Pharmerit International, where significant contributions involved leading HEOR studies and developing payer evidence strategies. Educational qualifications include a Ph.D. in Health Outcomes and Pharmacy Practice from The University of Texas at Austin, along with a Master's degree in Pharmaceutical Sciences and a Bachelor's degree in Economics from Peking University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices